Post-approval upper airway stimulation predictors of treatment effectiveness in the ADHERE registry

Clemens Heiser, Armin Steffen, Maurits Boon, Benedikt Hofauer, Karl Doghramji, Joachim T. Maurer, J. Ulrich Sommer, Ryan Soose, Patrick J. Strollo, Richard Schwab, Erica Thaler, Kirk Withrow, Alan Kominsky, Christopher Larsen, Eric J. Kezirian, Jennifer Hsia, Stanley Chia, John Harwick, Kingman Strohl, Reena Mehra

Source: Eur Respir J, 53 (1) 1801405; 10.1183/13993003.01405-2018
Journal Issue: January
Disease area: Sleep and breathing disorders

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Clemens Heiser, Armin Steffen, Maurits Boon, Benedikt Hofauer, Karl Doghramji, Joachim T. Maurer, J. Ulrich Sommer, Ryan Soose, Patrick J. Strollo, Richard Schwab, Erica Thaler, Kirk Withrow, Alan Kominsky, Christopher Larsen, Eric J. Kezirian, Jennifer Hsia, Stanley Chia, John Harwick, Kingman Strohl, Reena Mehra. Post-approval upper airway stimulation predictors of treatment effectiveness in the ADHERE registry. Eur Respir J, 53 (1) 1801405; 10.1183/13993003.01405-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The Spanish national clinical audit on COPD exacerbations. results of a pilot study: spirometry outcomes
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008


Economic evaluation of the impact of exacerbation frequency in COPD patients treated with single-inhaler triple therapy in Spain: The IMPACT trial
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Prescription patterns and treatment adherence of asthma controller therapy in children in a Dutch primary care database
Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma
Year: 2013


Patterns of risk of death and asthma-related adverse outcomes in adult asthma patients receiving long-acting β2-agonist (LABA) therapy: results from the UK general practice research database (GPRD)
Source: Annual Congress 2009 - Asthma treatment and control strategies in primary care
Year: 2009


Persistence to COPD therapies and impact on exacerbations: a French claims data study
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018




Characteristics and treatment regimens across ERS SHARP severe asthma registries
Source: Eur Respir J, 55 (1) 1901163; 10.1183/13993003.01163-2019
Year: 2020



Characteristics and treatment regimens across ERS SHARP severe asthma registries
Source: International Congress 2019 – Exacerbations and clinical impact of airway diseases
Year: 2019



A national database study of the effectiveness of switching real-life asthma patients to fostair
Source: International Congress 2015 – New data on established treatments for asthma, COPD and bronchiectasis
Year: 2015


Appropriateness of referrals to a fast track lung cancer clinic in the UK and effect on patient outcome
Source: Eur Respir J 2007; 30: Suppl. 51, 432s
Year: 2007

The association between COPD treatment adherence and patient outcomes in Europe and the US
Source: International Congress 2016 – Asthma, COPD, and ACOS: physical activity, dietary aspects, and diseases burden
Year: 2016


Effect of QVA149 on lung function in the subgroup of patients with a history of exacerbations in the previous year and baseline ICS use from the SHINE study
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014


Comparison of LAMA/LABA vs ICS/LABA in high risk COPD patients: Pre-specified analysis on lung function and health status from the IMPACT trial
Source: International Congress 2018 – COPD management
Year: 2018


Use and utility of an early presentation and intervention in COPD (EPIC) service
Source: Annual Congress 2009 - Healthcare and treatment of COPD
Year: 2009

Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015

Clinical predictors of airway obstruction in primary care
Source: International Congress 2017 – Primary care management of asthma and self-management of respiratory disease
Year: 2017

Recruiting to telehealth has a role during discharge planning in COPD: A feasibility and acceptability study
Source: Annual Congress 2013 –The latest insights in chronic care
Year: 2013


Efficacy of long-term educational program (EP) of patients with COPD
Source: Annual Congress 2010 - COPD: diagnosis
Year: 2010


The primary care routine data registry BeoNet: First pilot phase results for COPD research
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015

Ten-year projected outcomes associated with increased use of triple therapies in UK patients with COPD using the COPD Health Outcome Policy and INtervention (CHOPIN) model
Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data
Year: 2021